Chronos Archive seal
The Human Record

Arthur Ashe

Case HR-ML013-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
July 10, 1943 – February 6, 1993
Synthetic DOB
1943-07-10
Index visit
1989-01-12 at age 45
Synthetic MRN
HR-ML013-SYN-TD

Teaching objective: Person-first, confidential primary care for a 45-year-old man four months after HIV was diagnosed with cerebral toxoplasmosis, who also has coronary artery disease after two bypass operations: viral load and CD4 monitoring on bictegravir, emtricitabine, and tenofovir alafenamide (an antiretroviral regimen chosen to avoid interactions with his statin and cardiac medicines and to avoid abacavir), trimethoprim-sulfamethoxazole maintenance and its safe discontinuation by CD4 count, vaccines for adults with HIV, and secondary prevention of coronary disease to an LDL goal below 55 mg/dL, on the DHHS and IAS-USA antiretroviral guidance, the DHHS opportunistic infection guidelines, the HIVMA/IDSA primary care guidance, and the CMID ischemic heart disease and hyperlipidemia monographs.

Historical timeline

DateEventClaims
July 10, 1943Born in Richmond, Virginia.CLM-0001
July 31, 1979Heart attack while teaching tennis to young people.CLM-0002
1979Quadruple coronary artery bypass surgery.CLM-0002
1983Second (double) bypass operation, with a blood transfusion.CLM-0003, CLM-0005
1988Brain surgery for a mass found to be toxoplasmosis; HIV diagnosed.CLM-0004
April 8, 1992Announced publicly that he had HIV.CLM-0006
February 6, 1993Died in New York City.CLM-0008

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Arthur Robert Ashe Jr. was born in Richmond, Virginia, on July 10, 1943, to Mattie Cunningham Ashe and Arthur Robert Ashe Sr.; his mother died before he was seven. confirmed Arthur Ashe (1943-1993) supports
D On July 31, 1979, while teaching tennis to inner-city youth, Ashe had a heart attack, and he then underwent quadruple coronary artery bypass surgery in 1979.
The anchor for the synthetic coronary artery disease and old myocardial infarction. One source dates a first heart attack to July 1976; the 1979 date is preferred (see sources.md).
confirmed Arthur Ashe (1943-1993) supports
Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Arthur Ashe supports
Markel H. Arthur Ashe's other great serve: as activist for health disputes
D When chest pain recurred, Ashe had a second bypass operation, a double bypass, in 1983, during which he received a blood transfusion.
The anchor for two bypass operations.
confirmed Arthur Ashe (1943-1993) supports
Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
D In 1988 Ashe had difficulty moving his right hand and arm; a scan showed a mass in the left side of his brain, which surgeons removed, and the diagnosis was toxoplasmosis. Testing then showed that he had HIV and AIDS.
The anchor for the synthetic HIV disease with a history of cerebral toxoplasmosis. The month of the operation was not verified in a fetched source.
confirmed Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
Arthur Ashe supports
D Ashe and his doctors concluded that he had almost certainly acquired HIV from a blood transfusion during his 1983 heart operation, before blood was tested for the virus.
Documents the route of acquisition; the modern frame keeps it as history only (see sources.md).
confirmed Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
Arthur Ashe supports
D Ashe kept his diagnosis private at first, telling only a few family members and friends. On April 8, 1992, after learning that USA Today planned to report it, he announced at a press conference that he had HIV.
After the true-frame index date; recorded in the timeline. Supports the episode's emphasis on his control over disclosure.
confirmed Arthur Ashe (1943-1993) supports
Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
D Both of Ashe's parents had atherosclerotic heart disease at early ages. His mother died at 27 of complications from surgery, and his father had two heart attacks, at 55 and at 59.
Family history of early coronary disease.
confirmed Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
D Ashe died in New York City on February 6, 1993, aged 49, of AIDS-related pneumonia. His memoir, Days of Grace, was published after his death.
Recorded as a fact without detail; after the episode.
confirmed Arthur Ashe (1943-1993) supports
Markel H. Arthur Ashe's other great serve: as activist for health supports
Arthur Ashe supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection active confirmed both_with_link CLM-0004, CLM-0005
S Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy active confirmed both_with_link CLM-0004
S Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1942 and 1946 operations active confirmed both_with_link CLM-0002, CLM-0003
S Old myocardial infarction at age 36 active confirmed both_with_link CLM-0002
S Hyperlipidemia, on high-intensity statin active confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1989-01-12 HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 42 {copies}/mL (high)
Reference Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected
http://loinc.org · 20447-9
S 1989-01-12 CD3+CD4+ (T4 helper) cells [#/volume] in Blood 156 /uL (low)
Reference 500-1500 /uL
http://loinc.org · 24467-3
S 1989-01-12 Leukocytes [#/volume] in Blood by Automated count 4.2 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1989-01-12 Hemoglobin [Mass/volume] in Blood 13 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1989-01-12 Platelets [#/volume] in Blood by Automated count 198 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1989-01-12 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1989-01-12 Potassium [Moles/volume] in Serum or Plasma 4.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1989-01-12 Creatinine [Mass/volume] in Serum or Plasma 1.18 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1989-01-12 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 78 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1989-01-12 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1989-01-12 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1989-01-12 Cholesterol [Mass/volume] in Serum or Plasma 158 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1989-01-12 Cholesterol in HDL [Mass/volume] in Serum or Plasma 40 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1989-01-12 Triglyceride [Mass/volume] in Serum or Plasma 150 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1989-01-12 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 88 mg/dL
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1989-01-12 Hemoglobin A1c/Hemoglobin.total in Blood 5.4%
Reference <=5.6%
http://loinc.org · 4548-4
S 1989-01-12 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1989-01-12 Total score [AUDIT-C] 1 http://loinc.org · 75626-2
S 1989-02-09 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1989-02-09 Potassium [Moles/volume] in Serum or Plasma 4.8 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1989-02-09 Creatinine [Mass/volume] in Serum or Plasma 1.16 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1989-02-09 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 79 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1989-02-09 Glucose [Mass/volume] in Serum or Plasma 90 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1989-04-13 HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 0 {copies}/mL
Reference Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected
http://loinc.org · 20447-9
S 1989-04-13 CD3+CD4+ (T4 helper) cells [#/volume] in Blood 218 /uL (low)
Reference 500-1500 /uL
http://loinc.org · 24467-3
S 1989-04-13 Leukocytes [#/volume] in Blood by Automated count 4.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1989-04-13 Hemoglobin [Mass/volume] in Blood 13.6 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1989-04-13 Platelets [#/volume] in Blood by Automated count 224 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1989-04-13 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1989-04-13 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1989-04-13 Creatinine [Mass/volume] in Serum or Plasma 1.15 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1989-04-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 80 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1989-04-13 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1989-04-13 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 U/L
Reference 7-56 U/L
http://loinc.org · 1742-6
S 1989-04-13 Cholesterol [Mass/volume] in Serum or Plasma 118 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1989-04-13 Cholesterol in HDL [Mass/volume] in Serum or Plasma 41 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1989-04-13 Triglyceride [Mass/volume] in Serum or Plasma 125 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1989-04-13 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 52 mg/dL
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 1989-04-13 Lipoprotein a [Mass/volume] in Serum or Plasma 24 mg/dL
Reference <=29 mg/dL
http://loinc.org · 10835-7
S 1989-04-13 Hepatitis B virus surface Ab [Units/volume] in Serum 86 m[IU]/mL
Reference >=10 m[IU]/mL
http://loinc.org · 16935-9
S 1989-07-13 HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 0 {copies}/mL
Reference Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected
http://loinc.org · 20447-9
S 1989-07-13 CD3+CD4+ (T4 helper) cells [#/volume] in Blood 262 /uL (low)
Reference 500-1500 /uL
http://loinc.org · 24467-3
S 1989-07-13 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1989-07-13 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1989-07-13 Creatinine [Mass/volume] in Serum or Plasma 1.14 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1989-07-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 80 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1989-07-13 Glucose [Mass/volume] in Serum or Plasma 93 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1989-07-13 Albumin/Creatinine [Mass Ratio] in Urine 12 mg/g
Reference <=29 mg/g
http://loinc.org · 9318-7
S 1989-07-13 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 http://loinc.org · 44261-6
S 1989-08-17 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1989-08-17 Total score [AUDIT-C] 1 http://loinc.org · 75626-2
S 1989-10-19 HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 0 {copies}/mL
Reference Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected
http://loinc.org · 20447-9
S 1989-10-19 CD3+CD4+ (T4 helper) cells [#/volume] in Blood 318 /uL (low)
Reference 500-1500 /uL
http://loinc.org · 24467-3
S 1989-10-19 Leukocytes [#/volume] in Blood by Automated count 5 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1989-10-19 Hemoglobin [Mass/volume] in Blood 14.1 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1989-10-19 Platelets [#/volume] in Blood by Automated count 236 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1989-10-19 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1989-10-19 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1989-10-19 Creatinine [Mass/volume] in Serum or Plasma 1.12 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1989-10-19 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 82 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1989-10-19 Glucose [Mass/volume] in Serum or Plasma 91 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7

Synthetic vital signs

DateMeasureResultLOINCGrade
1989-01-12Body height185 cm8302-2S
1989-01-12Body weight72 kg29463-7S
1989-01-12Body mass index (BMI) [Ratio]21 kg/m239156-5S
1989-01-12Systolic blood pressure118 mm[Hg]8480-6S
1989-01-12Diastolic blood pressure74 mm[Hg]8462-4S
1989-01-12Heart rate72 /min8867-4S
1989-01-12Respiratory rate14 /min9279-1S
1989-01-12Body temperature36.7 Cel8310-5S
1989-01-12Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1989-02-09Body height185 cm8302-2S
1989-02-09Body weight72.6 kg29463-7S
1989-02-09Body mass index (BMI) [Ratio]21.2 kg/m239156-5S
1989-02-09Systolic blood pressure116 mm[Hg]8480-6S
1989-02-09Diastolic blood pressure72 mm[Hg]8462-4S
1989-02-09Heart rate70 /min8867-4S
1989-02-09Respiratory rate14 /min9279-1S
1989-02-09Body temperature36.6 Cel8310-5S
1989-02-09Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1989-04-13Body height185 cm8302-2S
1989-04-13Body weight73.8 kg29463-7S
1989-04-13Body mass index (BMI) [Ratio]21.6 kg/m239156-5S
1989-04-13Systolic blood pressure120 mm[Hg]8480-6S
1989-04-13Diastolic blood pressure74 mm[Hg]8462-4S
1989-04-13Heart rate68 /min8867-4S
1989-04-13Respiratory rate14 /min9279-1S
1989-04-13Body temperature36.7 Cel8310-5S
1989-04-13Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1989-07-13Body height185 cm8302-2S
1989-07-13Body weight74.6 kg29463-7S
1989-07-13Body mass index (BMI) [Ratio]21.8 kg/m239156-5S
1989-07-13Systolic blood pressure118 mm[Hg]8480-6S
1989-07-13Diastolic blood pressure72 mm[Hg]8462-4S
1989-07-13Heart rate66 /min8867-4S
1989-07-13Respiratory rate14 /min9279-1S
1989-07-13Body temperature36.6 Cel8310-5S
1989-07-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1989-10-19Body height185 cm8302-2S
1989-10-19Body weight75 kg29463-7S
1989-10-19Body mass index (BMI) [Ratio]21.9 kg/m239156-5S
1989-10-19Systolic blood pressure120 mm[Hg]8480-6S
1989-10-19Diastolic blood pressure74 mm[Hg]8462-4S
1989-10-19Heart rate66 /min8867-4S
1989-10-19Respiratory rate14 /min9279-1S
1989-10-19Body temperature36.6 Cel8310-5S
1989-10-19Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1989-08-17Body height185 cm8302-2S
1989-08-17Body weight74.8 kg29463-7S
1989-08-17Body mass index (BMI) [Ratio]21.9 kg/m239156-5S
1989-08-17Systolic blood pressure118 mm[Hg]8480-6S
1989-08-17Diastolic blood pressure72 mm[Hg]8462-4S
1989-08-17Heart rate64 /min8867-4S
1989-08-17Respiratory rate14 /min9279-1S
1989-08-17Body temperature36.6 Cel8310-5S
1989-08-17Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
HIV-1 viral load not detected by the three-month visit1989-04-13completedViral load not detected (below 20 copies/mL) at three months, and at six and nine months
CD4 count above 200 cells/uL for more than six months with an undetectable viral load, so that maintenance therapy can stop safely1989-10-19completedCD4 218 at three months, 262 at six months, and 318 at nine months; trimethoprim-sulfamethoxazole stopped
LDL cholesterol below 55 mg/dL by the three-month visit1989-04-13completedLDL cholesterol 52 mg/dL on atorvastatin and ezetimibe
Hepatitis B vaccine series completed with a protective antibody level by the three-month visit1989-04-13completedHepatitis B surface antibody 86 mIU/mL
Keep blood pressure below 130/80 mmHg1989-07-13completedBlood pressure 116 to 120 over 72 to 74 at every visit

Interventions

InterventionStatusGuideline
Antiretroviral therapy with bictegravir, emtricitabine, and tenofovir alafenamide once daily, chosen for its high barrier to resistance and few interactions with his cardiac medicines; viral load and CD4 count every three monthscompletedGL-DHHS-ART, GL-IAS-ART-2024, GL-HIVMA-PC-2020
Infectious diseases consultation to co-manage HIV: the regimen and its interactions, opportunistic-infection prophylaxis, the monitoring schedule, and vaccinescompletedGL-DHHS-ART, GL-DHHS-OI
Toxoplasma maintenance therapy with trimethoprim-sulfamethoxazole double strength twice daily, which also prevents Pneumocystis pneumonia, until the CD4 count is above 200 for more than six months on suppressive therapy; blood count, potassium, and creatinine every three months while on itcompletedGL-DHHS-OI
Secondary prevention of coronary disease after two bypass operations: aspirin, high-intensity atorvastatin with ezetimibe added for an LDL goal below 55 mg/dL, blood pressure below 130/80, a heart-healthy diet, regular exercise, and a written chest-pain plan with sublingual nitroglycerincompletedGL-CCD-2023, GL-CMID-2026
Vaccines for adults with HIV: pneumococcal, hepatitis B with an antibody check afterwards, the two-dose meningococcal ACWY series, recombinant zoster, and seasonal influenza and COVID-19, with no live vaccines while the CD4 count is below 200completedGL-CDC-IMZ-HIV, GL-HIVMA-PC-2020
Person-first, confidential care: he decides who learns of his diagnosis; support with disclosure if and when he chooses, peer support, and depression screening with the PHQ-9 at intake and six months and the PHQ-2 at the preventive visitcompletedGL-HIVMA-PC-2020, GL-USPSTF-DEP-2023, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Arthur Ashe (1943-1993) Encyclopedia Virginia (Virginia Humanities) scholarly
SRC-0002 Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis? STAT scholarly
SRC-0003 Markel H. Arthur Ashe's other great serve: as activist for health PBS NewsHour scholarly
SRC-0004 Arthur Ashe Biography.com (A&E Television Networks) other
SRC-0005 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the choice of TMP-SMX as toxoplasmosis maintenance, the timing of its discontinuation, and the LDL goal.
provenance reviewnot_startedRecent-death rule: only what Ashe made public himself and what was reported publicly, from Encyclopedia Virginia, STAT, PBS NewsHour, and Biography.com. The 1976 heart-attack date in one source is recorded as a dispute.
safe messaging reviewnot_startedHIV claims are marked sensitive; the language is person-first; disclosure is his own decision throughout; death recorded without detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.